Clinical Trial Update: The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating the combination of interferon beta and vitamin D in relapsing-remitting multiple sclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Carmel Medical Center | Conditions: MULTIPLE SCLEROSIS | Phase 4 | Status: TERMINATED